Larimar Therapeutics, Inc. (LRMR) Social Stream



Larimar Therapeutics, Inc. (LRMR): $7.59

0.32 (+4.40%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add LRMR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#164 of 365

in industry

LARIMAR THERAPEUTICS INC (LRMR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering LARIMAR THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 3 $26.43 $19 $22.715 $4.65 388.49%
2022-02-15 2 $26.43 $3 $14.715 $4.65 216.45%
2022-05-12 2 $3 $3 $3 $4.65 -35.48%
2022-09-19 3 $16 $16 $16 $4.65 244.09%
2022-09-20 3 $16 $10 $13 $4.65 179.57%
2022-11-11 4 $16 $10 $12.666 $4.65 172.39%
2023-02-10 5 $16 $4 $10.5 $4.65 125.81%
2023-05-15 5 $16 $4 $11.5 $4.65 147.31%
2023-05-16 5 $15 $4 $11.25 $4.65 141.94%
2023-08-10 5 $15 $4.5 $11.375 $4.65 144.62%
2023-08-15 5 $17 $4.5 $11.833 $4.65 154.47%
NA 2 $NA $NA $NA $4.65 NA%

The Trend in the Analyst Price Target


LRMR's average price target has moved up $2.52 over the prior 46 months.

LRMR reports an average of 168.37% for its upside potential over the past 27 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-01 5 16 4.0 11.500 5.82 97.59%
2023-05-15 5 16 4.0 11.500 3.59 220.33%
2023-05-16 5 15 4.0 11.250 3.65 208.22%
2023-05-18 5 15 4.5 11.375 3.77 201.72%
2023-08-15 5 17 4.5 11.833 4.18 183.09%

LRMR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 153 days, LRMR's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LRMR as an investment opportunity.

  • LRMR has a greater number of analysts covering the stock than 196.3% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, LARIMAR THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1224.17% of them.
  • In terms of how LARIMAR THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is higher than 246.3% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, LARIMAR THERAPEUTICS INC's variance in analysts' estimates is lower than -561.26% of them.

In the Pharmaceutical Products industry, ALDX, IMUX, and KURA are the three stocks most similar to LARIMAR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is LRMR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!